|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
Differentiation of embryonic stem (ES) cells generally
occurs after formation of three-dimensional
cell aggregates, known as embryoid bodies (EBs). This
differentiation occurs
following suspension culturing of EBs in media containing
a high glucose (25 mM)
concentration. Although high glucose-containing media is
used for maintenance and proliferation
of ES cells, it has not been demonstrated whether this is
a necessary requirement for EB
development. To address this, we examined the growth and
differentiation of EBs established in
0 mM, 5.5 mM (physiological) and 25 mM (high) glucose
concentrations, through morphometric
analysis and examination of gene and protein expression.
The effect on EB development of
supplementation with basic fibroblast growth factor (FGF2)
was also studied. We report that the
greatest rate of EB growth occurs in 5.5 mM glucose media.
A morphological study of EBs over
104 days duration under glucose-containing conditions
demonstrated the development of all
three major embryonic cell types. The difference from
normal human development was obvious
in the lack of rostro-caudal control by the notochord. In
the latest stages of development the main
tissue observed appeared to be cartilage and cells of a
mesodermal lineage. We conclude that
physiological glucose concentrations are suitable for the
culturing of EBs, the addition of FGF2
enhances the temporal expression of genes including
POU5F1, nestin, FOXA2, ONECUT1,
NEUROD1, PAX6, and insulin, and that EBs can
be cultured in vitro for long periods, allowing
for further examination of developmental processes.
Key words:
Embryo
Developmental biology
Early development
Gene regulation
This article has been cited by other articles:
![]() |
G. M. Hoben, E. J. Koay, and K. A. Athanasiou Fibrochondrogenesis in Two Embryonic Stem Cell Lines: Effects of Differentiation Timelines Stem Cells, February 1, 2008; 26(2): 422 - 430. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |